FDA Educates Healthcare Professionals On Marijuana, Hemp And The Emerging Cannabinoid Market

Federal officials from the U.S. Food and Drug Administration (FDA) met this week for a wide-ranging educational webinar about cannabis, outlining matters such as the plant’s chemical makeup, differences between marijuana and hemp, clinical and therapeutic effects of cannabinoids as well as ongoing